Back to Search
Start Over
Rhino-orbital-cerebral mucormycosis in COVID-19 patients - Taming the black evil with pharmacological weapons.
- Source :
-
Indian journal of pharmacology [Indian J Pharmacol] 2021 Sep-Oct; Vol. 53 (5), pp. 417-419. - Publication Year :
- 2021
-
Abstract
- Competing Interests: None
- Subjects :
- Antifungal Agents adverse effects
COVID-19 immunology
COVID-19 virology
Central Nervous System Fungal Infections immunology
Central Nervous System Fungal Infections microbiology
Eye Infections, Fungal immunology
Eye Infections, Fungal microbiology
Host-Pathogen Interactions
Humans
Mucorales immunology
Mucorales pathogenicity
Mucormycosis immunology
Mucormycosis microbiology
Nose Diseases immunology
Nose Diseases microbiology
Orbital Diseases immunology
Orbital Diseases microbiology
Risk Factors
SARS-CoV-2 immunology
SARS-CoV-2 pathogenicity
Treatment Outcome
Antifungal Agents therapeutic use
COVID-19 complications
Central Nervous System Fungal Infections drug therapy
Eye Infections, Fungal drug therapy
Mucorales drug effects
Mucormycosis drug therapy
Nose Diseases drug therapy
Orbital Diseases drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1998-3751
- Volume :
- 53
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Indian journal of pharmacology
- Publication Type :
- Editorial & Opinion
- Accession number :
- 34854414
- Full Text :
- https://doi.org/10.4103/ijp.ijp_392_21